Kevin Hamblett
Seminars
Wednesday 10th March 2027
Treating Cancer From the Outside In: The Preclinical & Early Clinical Development of PF-08052667 for Non Muscle Invasive Bladder Cancer
- Preclinical optimisation of ADC for local bladder treatment
- Strong preclinical efficacy with limited systemic exposure
- Clinical development of PF-08052667
